Amyl Therapeutics
Enterprise number 0758775372 · Active (000 Normale toestand)
Amyl Therapeutics is a besloten vennootschap registered in Liège, Belgium, incorporated on 26 Nov 2020. Its registered activity is speur- en ontwikkelingswerk op biotechnologisch gebied. Our model estimates a 0.00 % probability that it becomes insolvent within 12 months, 0.2 times the average for active companies (low risk).
Insolvency risk, next 12 months
Higher than 32 % of active companies in Belgium. 0.2× the average annual insolvency rate (0.01 %).
Raises the risk
Nothing notable.
Lowers the risk
Each factor compares companies in the same group (for example the same age band) with the average. The score is a statistical estimate from public data (model AUC 0.89, trained 8 Nov 2026), not a credit rating. How it works.
Company details
- Enterprise number
- 0758775372 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 26 Nov 2020 (6 years)
- Registered address
- 4000 Liège
- Province
- Liège
- Activity
- 72110 Speur- en ontwikkelingswerk op biotechnologisch gebied
- Industry
- Scientific research and development
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Liège
- " Akontio " Huy
- 2Make Sense Aywaille
- AARDEX Group Seraing
- ACT-W Nandrin
- AEXYRA BIO Liège
- AGRA-OST Sankt Vith
- AJD Services Herve
- ALGAMA INDUSTRY Grâce-Hollogne
- ALIZES PHARMA Seraing
- AQUILON PHARMACEUTICALS Seraing
- AQUITEC PHARMA Seraing
- ARAPONICS Liège
Questions about Amyl Therapeutics
What is the enterprise number of Amyl Therapeutics?
Amyl Therapeutics is registered under enterprise number 0758775372 in the official register of Belgium. View it at the official register.
Is Amyl Therapeutics still active?
Yes. Amyl Therapeutics is registered as active (status: 000 Normale toestand).
Has Amyl Therapeutics gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for Amyl Therapeutics in the official data.
How likely is Amyl Therapeutics to become insolvent?
Our model estimates a 0.00 % probability that Amyl Therapeutics becomes insolvent within the next 12 months (low risk). That is higher than 32 % of active companies in Belgium.
When was Amyl Therapeutics founded?
Amyl Therapeutics was incorporated on 26 Nov 2020.
Where is Amyl Therapeutics registered?
Amyl Therapeutics's registered address is in 4000 Liège (Liège), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 9 Nov 2026.